Tucker Anthony Cleary Gull Announces Investment Opinion on Cephalon, Inc.DENVER--(BUSINESS WIRE)--Oct. 28, 1999-- Tucker Anthony Cleary Gull Initiates Coverage of Cephalon Ceph´a`lon n. 1. (Zool.) The head. , Inc. Tucker Anthony Cleary Gull today announced that it is initiating coverage of Cephalon, Inc., an emerging specialty biopharmaceutical company that develops and markets novel therapeutics to treat neurological disorders. Senior analyst Charles C. Duncan, Ph.D., gives Cephalon stock (Nasdaq: CEPH CEPH Council on Education for Public Health CEPH Centre d'Etude du Polymorphisme Humain ) a top rating of Strong Buy. According to Duncan, Cephalon represents a company in rapid transition, from a development-stage research boutique to a commercial-stage specialty pharmaceutical enterprise. "We believe that Cephalon shares are undervalued Undervalued A stock or other security that is trading below its true value. Notes: The difficulty is knowing what the "true" value actually is. Analysts will usually recommend an undervalued stock with a strong buy rating. relative to the equity of comparable companies and earnings-growth potential of its existing products," said Duncan. "Cephalon presents a compelling investment opportunity." Based in West Chester, Penn., Cephalon markets Provigil, a treatment for daytime sleepiness associated with narcolepsy narcolepsy, a sleep disorder characterized by excessive daytime sleepiness and recurring unwanted episodes of sleep ("sleep attacks"). People with narcolepsy may abruptly fall asleep at almost any time, including while talking, eating, or even walking. , and Gabitril, an epilepsy treatment. The company also has several early-stage products in development for neurodegenerative disorders and cancer. About Tucker Anthony Cleary Gull Tucker Anthony Cleary Gull is a national investment banking firm focused on businesses of the next millennium and the institutional investors who follow emerging growth and mid-cap companies. In 1998, the firm executed over $3 billion of advisory, principal and financing transactions, including $1.3 billion in public offerings. Its 20 senior research analysts follow trends and companies in six industries, including healthcare/life sciences. The firm operates full-service offices in Boston, Denver, Milwaukee and New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of and is part of Freedom Securities. Listed on the New York Stock Exchange New York Stock Exchange (NYSE) World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City. , Freedom Securities is approximately 50% owned by its employees and Boston-based Thomas H. Lee Company. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion